Stifel Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Stifel Financial's AMRX Position: Q3 2026 in Review
Stifel Financial increased its Amneal Pharmaceuticals (AMRX) stake by 5.3% in Q3 2026, buying an estimated $203K and bringing the position to 224,857 shares worth $4.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1464.
Stifel Financial first reported a position in AMRX in Q2 2018 and has held it in 25 quarters since. The position peaked at $10.1M in Q2 2018. 332 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Stifel Financial held 224,857 shares of Amneal Pharmaceuticals worth $4.53M as of Q3 2026.
- Stifel Financial bought 11,260 Amneal Pharmaceuticals shares in Q3 2026, an estimated $203K.
- Amneal Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #1464 holding.
- Stifel Financial first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 25 quarters since.
- Stifel Financial's Amneal Pharmaceuticals position peaked at $10.1M in Q2 2018.
- 332 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.